Jane E. Kiernan - Aug 5, 2021 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role
Director
Signature
/s/ Dan Dearen, as Attorney-in-Fact for Jane E. Kiernan
Stock symbol
AXNX
Transactions as of
Aug 5, 2021
Transactions value $
-$72,248
Form type
4
Date filed
7/7/2022, 08:20 PM
Previous filing
May 28, 2021
Next filing
Nov 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $210K +10K +131.68% $21.04 17.6K Aug 5, 2021 Direct
transaction AXNX Common Stock Options Exercise $142K +4.17K +23.68% $34.10 21.8K Aug 5, 2021 Direct
transaction AXNX Common Stock Sale -$110K -1.75K -8.04% $62.71 20K Apr 1, 2022 Direct F1
transaction AXNX Common Stock Sale -$315K -5.25K -26.24% $60.00 14.8K Jul 5, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -4.17K -100% $0.00* 0 Aug 5, 2021 Common Stock 4.17K $34.10 Direct F2
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -10K -100% $0.00* 0 Aug 5, 2021 Common Stock 10K $21.04 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 The shares subject to the option will vest in full on August 22, 2020.
F3 The shares subject to the option will vest in full on April 8, 2020.